Sr. Director, US Team Lead, LORBRENA/BRAF Lung

Role: Senior commercial leader overseeing the US Precision Medicine Thoracic Franchise for Pfizer's oncology portfolio, focusing on biomarker-driven therapies for NSCLC, including LORBRENA and BRAFTOVI + MEKTOVI. Responsibilities: develop and execute AI-enabled marketing strategies leveraging machine learning, predictive analytics, and next-best-action tools; lead cross-functional teams to align brand, diagnostic, and customer engagement strategies; set multi-year portfolio visions, anticipate market shifts, and shape lifecycle management; connect marketing efforts to patient outcomes through metrics and feedback loops; coordinate with Market Access to address reimbursement challenges; lead and develop a high-performing marketing team; influence senior leadership with strategic insights; ensure compliance and effective communication across channels. Qualifications: 12+ years pharma experience with proven success in AI/data-driven marketing, US product launches, and lifecycle management; strong leadership, strategic thinking, cross-functional collaboration, and communication skills; experience in oncology or biomarker-driven therapies preferred. High-Value: oncology (NSCLC), biomarker-driven, precision medicine, AI-enabled marketing, lifecycle planning, cross-functional leadership, US market. Work Setup: multiple US locations, some travel (~20%), fast-paced, data-rich environment.